Catching Up With Past and Present Beiersdorf Residents of Distinction
Beiersdorf’s Residents of Distinction program mentor and former mentee Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, chats with his mentee Dawn Queen, MD, a Resident at Columbia University Irving Medical Center in New York City, about her experience as one of this year’s five […]
Three’s the Charm: Learn Why Acne Experts Are So Excited About Cabtreo
Linda F. Stein Gold, MD, Director of Dermatology Clinical Research at Henry Ford Hospital in Detroit, shares why she is so excited about the availability of Cabtreo (clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide. Ortho Dermatologics) for acne.
Master Class: Recognizing and Avoiding Filler Complications
Joel L. Cohen, MD, a dermatologist and the Director of AboutSkin Dermatology and DermSurgery in Greenwood Village and Lone Tree, CO, offers expert advice on how to treat filler complications such as sensitivity, delayed nodules, infection, necrosis, superficial placement, asymmetry, and more in this Master Class.
Treating AD in Kids: The Dawn of a New Day
Lawrence Eichenfield, MD, Chief of Pediatric and Adolescent Dermatology at Rady Children’s Hospital-San Diego and Professor of Dermatology and Pediatrics and Vice-chair of the Department of Dermatology at UC San Diego School of Medicine, discusses innovations in topical and systemic therapies for atopic dermatitis in kids.
Beyond Antihistamines: New Urticaria Treatments Target Mast Cells
New understandings about the pathophysiology of urticaria are paving the way for new treatments that target mast cell activation including dupilumab (Dupixent, Sanofi, and Regeneron) and Bruton Tyrosine Kinase (BTK) Inhibitors. Jason Hawkes, MD, MS, a dermatologist in Rocklin, CA., reviews the science.
Cabtreo Is Here: Are Your Acne Patients Ready?
Keep a running list of all patients who can benefit from Cabtreo (clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide, Ortho Dermatologics), advises Birmingham, AL-based dermatologist Julie C. Harper, MD, the Past President of the American Acne and Rosacea Society.
Beyond the Basics: Exploring the Role of AI in Dermatology
Jack Resneck, MD, Immediate Past President of the American Medical Association, and a dermatologist in San Francisco, discusses the promise and potential peril of augmented intelligence tools and other technologies currently being used in dermatology.
Advances in Skin Tightening
Energy-based devices, biostimulatory fillers, and topical skincare with exosomes, cytokines, and growth factors work together to maximize fibroblast production, explains Mitchel P. Goldman, MD, the Founder and Medical Director of Cosmetic Laser Dermatology and the Medical Director of Platinum Dermatology Partners in San Diego, CA.
Inside Dr. Hilary Baldwin’s Toolbox for Acne and Rosacea
Hilary Baldwin, MD, the Medical Director of the Acne Treatment & Research Center in Morristown, NJ, explains why she is so excited about new topical therapies, lasers, and changes to the Ipledge program in acne as well as new rosacea therapies.
Is it Really Tinea Capitis?
Tinea capitis isn’t always a slam-dunk diagnosis. Candrice R. Heath, MD, an Assistant Professor of Dermatology at the Lewis Katz School of Medicine at Temple University in Philadelphia, shares tips on how to differentiate tinea capitis from common mimickers such as seborrheic dermatitis.